Pilot study of combined therapy with ω-3 fatty acids and niacin in atherogenic dyslipidemia.

@article{Isley2007PilotSO,
  title={Pilot study of combined therapy with ω-3 fatty acids and niacin in atherogenic dyslipidemia.},
  author={William Luther Isley and John M. Miles and William S. Harris},
  journal={Journal of clinical lipidology},
  year={2007},
  volume={1 3},
  pages={211-7}
}
BACKGROUND Niacin and ω-3 fatty acids (ω-3 FA) are both nutrients that reduce serum triglyceride and raise high-density lipoprotein cholesterol (HDL-C) levels when used at pharmacological doses. The possibility that these two agents, given in combination, might have additive effects on these lipid parameters has not been examined previously. In addition, the combination might prevent the rise in low-density lipoprotein (LDL)-C levels frequently seen with ω-3 FA treatment. OBJECTIVE To… CONTINUE READING